<DOC>
	<DOCNO>NCT01798836</DOCNO>
	<brief_summary>To evaluate effect oestradiol pre-treatment combine ultrashort flare GnRH agonist /GnRH antagonist protocol</brief_summary>
	<brief_title>Oestradiol Pre-treatment Ultrashort Flare GnRH Agonist/GnRH Antagonist Protocol Poor Responders Undergoing IVF</brief_title>
	<detailed_description>The combined ultrashort flare GnRH agonist /GnRH antagonist protocol COH cycle result significantly high clinical pregnancy rate patient poor embryo quality , repeat IVF failure poor responder . This protocol combine effect microdose flare endogenous FSH release benefit immediate LH suppression GnRH antagonist . A major disadvantage use GnRH antagonist protocol limitation program cycle , drug administration start day 2 menstrual cycle strictly follow hCG criterion meet . The purpose study perform oestradiol pre-treatment combine ultrashort flare GnRH agonist /GnRH antagonist protocol aim 1. good programme antagonist cycle 2. improve IVF outcome parameter , production follicle / oocyte rise live birth rate .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Deslorelin</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Prolactin Release-Inhibiting Factors</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>Patients poor response previous COH IVF cycle Patients AMH &lt; 1 and/or FSH &gt; 12 Poor quality embryos previous cycle Age patient 44 year Patients normal ovarian reserve Patients sonographically detect hydrosalpinges Presence intramural fibroid distort endometrial cavity submucous myoma Asherman 's syndrome Women thrombofilia disorder</criteria>
	<gender>Female</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>IVF/ICSI cycle , poor responder , ultrashort flare protocol , antagonist protocol</keyword>
</DOC>